SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-003830
Filing Date
2020-11-12
Accepted
2020-11-12 08:08:20
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannapharmarx_10q-093020.htm 10-Q 581849
2 CERTIFICATION cannapharmarx_ex3101.htm EX-31.1 11586
3 CERTIFICATION cannapharmarx_ex3102.htm EX-31.2 11262
4 CERTIFICATION cannapharmarx_ex3200.htm EX-32 5103
  Complete submission text file 0001683168-20-003830.txt   3597537

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20200930.xml EX-101.INS 560789
6 XBRL SCHEMA FILE cpmd-20200930.xsd EX-101.SCH 40360
7 XBRL CALCULATION FILE cpmd-20200930_cal.xml EX-101.CAL 60467
8 XBRL DEFINITION FILE cpmd-20200930_def.xml EX-101.DEF 194434
9 XBRL LABEL FILE cpmd-20200930_lab.xml EX-101.LAB 293197
10 XBRL PRESENTATION FILE cpmd-20200930_pre.xml EX-101.PRE 262204
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 201303500
SIC: 2834 Pharmaceutical Preparations